Phibro Animal Health Corporation Class A (PAHC) — Analysis Summary
Phibro Animal Health Corporation Class A (PAHC) has a market cap of $1.34B with year-over-year revenue growth of +27.4%. Net margin stands at 3.7%. The stock trades at a P/E ratio of 14.1.
Key Takeaways
- Revenue changed +27.4% year-over-year
- Net margin of 3.7%
- P/E ratio of 14.1
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, PAHC posted revenue growth of +27.4% and trades at a P/E of 14.1.
Phibro Animal Health Corporation Class A (PAHC)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Sector
PHARMACEUTICAL PREPARATIONS
Employees
2,475
Headquarters
TEANECK, NJ
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.48
Dividend Yield
1.45%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.